| A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC (NCT05879068) | Biotheus Inc. | 2022-05-27 |
| A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (NCT05026593) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-09-07 |
| Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer (NCT04750239) | Y-mAbs Therapeutics | 2021-08-17 |
| Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers (NCT04802174) | National Cancer Institute (NCI) | 2021-06-01 |
| A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682) | Jacobio Pharmaceuticals Co., Ltd. | 2021-05-07 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer (NCT04684017) | Shanghai Chest Hospital | 2019-05-01 |
| Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] (NCT03428607) | Samsung Medical Center | 2018-10-17 |
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer (NCT03575793) | Salma Sabbour | 2018-09-06 |
| Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases (NCT03297788) | Juergen Debus | 2017-12-01 |
| Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment (NCT03244904) | Fujian Cancer Hospital | 2017-11-01 |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024) | PharmaMar | 2016-05-06 |
| A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (NCT02734004) | AstraZeneca | 2016-03-17 |
| Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC (NCT02990780) | Shanghai Chest Hospital | 2015-12-01 |
| A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations (NCT02109016) | Clovis Oncology, Inc. | 2014-04-01 |
| Pazopanib Maintenance for SCLC (NCT01797874) | Samsung Medical Center | 2013-06-01 |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection (NCT01829971) | Mirna Therapeutics, Inc. | 2013-04-01 |
| Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer (NCT01797159) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-03-11 |
| Pazopanib in Relapsed and Refractory Small Cell Lung Cancer (NCT01713296) | Hellenic Oncology Research Group | 2011-11-01 |
| Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation (NCT00522639) | Maastricht Radiation Oncology | 2008-10-01 |
| A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy (NCT00447421) | Eli Lilly and Company | 2007-02-01 |
| Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer (NCT00046787) | Astellas Pharma Inc | 2002-09-01 |
| BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00346385) | ImmunoGen, Inc. | 2002-03-01 |
| Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer (NCT07535359) | Daiichi Sankyo | |